ArticleCancer immunology, immunotherapy : CII2024

Leukocyte-associated immunoglobulin-like receptor-1 blockade in combination with programmed death-ligand 1 targeting therapy mediates increased tumour control in mice.

Akashdip Singh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.